SUBSCRIBE
SUBSCRIBE
News   Policy

US Panel Suggests Stricter Trial Safety Margins for Cerus Corporation (JOBS)

November 17, 2009 | 
1 min read
Bookmark and Share

Reuters -- Blood-safety products maker Cerus Corp (CERS.O) said an U.S. advisory committee recommended more stringent safety margins for a late-stage trial of its intercept blood system to treat platelets.
Regulatory
MORE ON THIS TOPIC
Investment volatility metaphor of riding roller coaster, financial stock market fluctuation rising up and falling down concept, people investors riding roller coaster on fluctuated market chart.
Earnings
Biotechs Report Regulatory Headaches, High-Stakes Catalysts During Q4 Earnings
March 13, 2026
 · 
5 min read
 · 
Annalee Armstrong
Insights
From Two Trials to One, Sponsors Face a Higher Standard
March 12, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker
Illustration of a yellow envelope on a blue background with a read warning symbol
GLP-1
Novo Hit With FDA Warning Letter for Unreported Ozempic Safety Signals
March 11, 2026
 · 
2 min read
 · 
Tristan Manalac
Contemporary art collage of human hands holding a arrow pointing up, graphs and diagrams. Concept of profit, making money, business. Copy space.
Duchenne muscular dystrophy
Capricor Shares Rise as FDA Sets August Decision Date for Rejected Duchenne Therapy
March 11, 2026
 · 
2 min read
 · 
Tristan Manalac